Magnitude of Tuberculosis, its associated risk factors, Rifampicin resistance, and multi- drug resistance rate among TB presumptive patients at five selected Public Hospitals, Somali Region, Eastern Ethiopia, 2025. Retrospective cross-sectional study
Summary by researchsquare.com
1 Articles
1 Articles
Magnitude of Tuberculosis, its associated risk factors, Rifampicin resistance, and multi- drug resistance rate among TB presumptive patients at five selected Public Hospitals, Somali Region, Eastern Ethiopia, 2025. Retrospective cross-sectional study
BackgroundTuberculosis (TB) is a major public health problem worldwide. In 2022, an estimated 10.6 million people fell ill with TB worldwide. Emergency of Rifampicin and multi-Drug resistance (RR/MDR) has posed greater public health threat on control and prevention of TB. Ethiopi...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium